Lyme disease is an infection caused by a tick-borne spirochete, Borrelia burgdorferi. It is the most common vector-borne disease in the United States (18, 37) . The hallmark of acute Lyme disease is the characteristic skin lesions, known as erythema migrans (EM) skin lesions. Other acute clinical manifestations result from dissemination of the spirochete to the central and peripheral nervous systems, the heart, and the musculoskeletal system (7, 21, 36) .
Some bacteria that disseminate from a skin inoculation site secrete enzymes (e.g., collagenases and elastases) that are thought to participate in the spreading process by disrupting the extracellular matrix barrier (10, 22, 38) . B. burgdorferi does not secrete any enzymes capable of digesting collagen, laminin, or gelatin (22) . We have demonstrated that expression of matrix metalloproteinase 9 (MMP-9) was selectively upregulated in human EM skin lesions of acute Lyme disease. The activated fibroblasts and infiltrating mononuclear cells were the major sources of local MMP-9 production (43) . Infiltration of the skin with mononuclear cells is frequently observed in EM lesions of acute Lyme disease (3) . We hypothesize that bacterial induction of host proteases may play a major role in the dissemination of B. burgdorferi (43) .
CD14 on blood monocytes mediate monocyte/macrophage activation by lipopolysaccharide (LPS). LPS bound to CD14 may contribute to atherogenesis by stimulating macrophages to produce tumor necrosis factor alpha, interleukin 1 (IL-1), IL-6, IL-8, IL-12, alpha interferon, migration inhibitory factors, chemokines, eicosanoids, and reactive oxygen species, which in turn stimulate the production of a second wave of chemokines, cytokines, and adhesion and signaling molecules. The mature CD14 protein is present in two isoforms: membrane bound and soluble.
Membrane-associated CD14 (mCD14) is expressed on myeloid cells, including tissue macrophages, monocytes, promonocytes, and activated granulocytes. It is a glycoprotein with a molecular mass of 55 kDa, attached to the cell membrane by a glycosylphosphatidylinositol (GPI) anchor that lacks both transmembrane and cytoplasmic domains (4, 25) . It has been implicated in mediating inflammatory responses to many pathogen-derived ligands, including gram-positive bacterial peptidoglycan (PGN) and lipoteichoic acid (9, 42) , which is the major component of the cell wall of gram-positive bacteria and lipoproteins from spirochetes (35) . Soluble CD14 (sCD14) varies from about 43 to 53 kDa and lacks the GPI anchor but has the same amino acid sequence as mCD14. Both mCD14 and sCD14 can function as receptors for LPS of gram-negative bacteria and from various cell wall products of gram-positive bacteria. sCD14 enhances mCD14-mediated cell activation by LPS and PGN by binding LPS and PGN and then by transferring LPS and PGN to mCD14 (15) . sCD14 is a proinflammatory molecule which is increased in inflammation (24) . The effects of CD14 in the patients of acute Lyme disease, especially the relationship between CD14 and MMP-9, are not completely understood. In this study, we explored the effects of CD14 in pathogenesis of acute Lyme disease and the relationship between CD14 and MMP-9.
Master Mix reagents kit were as follows: reverse transcription, 48°C for 30 min; AmpII Taq Gold activation, 95°C for 10 min; there were 40 PCR cycles. A PCR cycle consisted of heating to 95°C for 15 s to denature and 60°C for 1 min for annealing/extension. Relative gene expression was calculated manually from the exported results, following the instructions of the ABI PRISM 7000 sequence detection system's manufacturer.
Western blot analysis. The cell lysates or supernatants from the cultured cells were electrophoresed on a 4 to 20% sodium dodecyl sulfate-polyacrylamide gel and electrophoretically transferred to polyvinylidene fluoride membranes. Membranes were blocked overnight at 4°C with 5% nonfat milk in TBST (10 mM Tris-HCl, pH 7.5, 140 mM NaCl, 1.5 mM MgCl 2 , 0.05% Tween 20) and incubated with the primary antibodies for 1 h. After three washes in TBST (10 min for each wash), the membranes were incubated with horseradish peroxidaseconjugated secondary antibodies in TBST. Immunoreactivity was detected using an enhanced chemiluminescence system (Amersham).
Enzyme-linked immunosorbent assay (ELISA). Human MMP-9 (total) and sCD14 (R&D Systems, Minneapolis, MN) were measured by immunoassay according to the manufacturer's instructions. Briefly, the serum was diluted 200-fold for sCD14 and 100-fold for MMP-9 using a calibrator diluent. The optical density of each well was determined within 30 min, using a microplate reader set to 450 nm and 540 nm.
Statistics. The results were presented as means Ϯ standard deviations and were analyzed using the Student t test. Statistical significance was determined to be a P value of Ͻ0.05.
RESULTS
Concentrations of MMP-9 and sCD14 in serum from the patients with acute Lyme disease. The concentration of MMP-9 and/or sCD14 in serum from patients with acute Lyme disease was determined by ELISA. As shown in Fig. 1 , the concentrations of both of MMP-9 (Fig. 1A) and sCD14 ( 1B) were significantly elevated for patients with acute Lyme disease compared to levels for healthy controls (P Ͻ 0.05). Upregulation of MMP-9 by stimulation of B. burgdorferi in U937 cells and fibroblasts. As assessed by gelatin zymography, the upregulation of the 92-kDa protein by B. burgdorferi was time and concentration dependent in U937 cells. The activity of the 72-kDa protein was not significantly different in the presence or absence of B. burgdorferi ( Fig. 2A and B) . Western blot analysis demonstrated that not only was the expression of MMP-9 (92 kDa) in the supernatants collected from U937 cells elevated (Fig. 2C ), the expression of MMP-9 (92 kDa) was also increased in U937 cell lysates, as determined using monoclonal antibody against MMP-9 ( Fig. 2D ) and monoclonal antibody against MMP-2 (for MMP-2, 72 kDa, data not shown). ␤-Actin was used as a control (Fig. 2E ). All gelatinolytic activity was inhibited when zymography was performed in the presence of 10 mM 1,10-phenanthroline, a specific inhibitor of MMPs. Stimulation of MMP-9 production by B. burgdorferi in U937 cells was not affected by 50 g/ml polymyxin B, an inhibitor of LPS activation (data not shown).
The mRNA expression of MMP-9 was also significantly increased in U937 cells in the presence of B. burgdorferi, as determined using real-time RT-PCR ( Fig. 2F ) and human MMP Nonrad-GEArrays (Fig. 2G ).
Functional activity of MMP-9 was not detected in fibroblasts in the presence or absence of B. burgdorferi by using gelatin zymography and a targeted gene array (data not shown). However, MMP-9 mRNA expression was detected when the moresensitive technique, real-time RT-PCR, was used. The expression of MMP-9 was not changed in fibroblasts with B. burgdorferi, using real-time RT-PCR (Fig. 3) . Nonetheless, when fibroblasts were incubated with the conditional medium (CM) (0.5 ml/ml) from the supernatants of U937 cells with B. burgdorferi, the expression of MMP-9 was significantly increased compared to results for fibroblasts with normal cultured medium (1 ml) (Fig. 3) . Furthermore, MMP-9 expression in fibroblasts with conditional medium (0.5 ml/ml) was much higher when B. burgdorferi was added than for fibroblasts with normal cultured medium (1 ml) in the presence of B. burgdorferi (Fig. 3) . However, there was no effect in the activity of MMP-9 in fibroblasts when the supernatants from U937 cells without B. burgdorferi were used.
Regulation of CD14 expression by stimulation of B. burgdorferi in U937 cells and fibroblasts. We assessed whether the expression of MMP-9 in U937 cells and fibroblasts with B. burgdorferi involved a CD14 signaling pathway. The U937 cells and fibroblasts were incubated in the presence or absence of B. burgdorferi. In Western blot analysis, not only the expression of mCD14 (55 kDa) (Fig. 4A ) but also the expression of sCD14 (48 kDa) ( Fig. 4C and D, equal volume of 10 l/well of supernatants) in U937 cells was elevated in the presence of B. burgdorferi in a time-and dose-dependent manner. ␤-Actin was used as a control (Fig. 4B) . The expression pattern of CD14 showed the same time-dependent trend as that of MMP-9 by stimulation of B. burgdorferi.
The mRNA expression of CD14 was also significantly increased from U937 cells in the presence of B. burgdorferi, using real-time RT-PCR (Fig. 4E) . Moreover, the expression of TLR2 was not significantly changed from U937 cells in the presence of B. burgdorferi (Fig. 4F) . However, the expression of CD14 (mCD14 or sCD14) in fibroblasts was not found in the presence or absence of B. burgdorferi (data not shown).
Effect of anti-CD14 antibody on upregulation of MMP-9 by B. burgdorferi in U937 cells and fibroblasts. To determine whether the upregulation of MMP-9 by B. burgdorferi was associated with the CD14 signaling pathway specifically, the U937 cells and/or fibroblasts were cultured with or without anti-CD14 antibody (monoclonal or polyclonal antibodies). When anti-CD14 antibody was added to U937 cells, the upregulation of MMP-9 by B. burgdorferi was partially blocked in a concentration-dependent manner (Fig. 5A and B) .
As mentioned above, not only the expression of mCD14 (Fig. 4A) but also the expression of sCD14 (Fig. 4C and D) in U937 cells was elevated in the presence of B. burgdorferi in a time-and dose-dependent manner as determined by Western blotting. When fibroblasts were incubated with CM (containing CD14), the expression of MMP-9 was significantly increased. Furthermore, the expression of MMP-9 was much higher when B. burgdorferi was added than for fibroblasts with normal cultured medium. This effect was completely blocked by anti-CD14 antibody (Fig. 3) .
Recombinant CD14 directly activates MMP-9 enzymatic activity in fibroblasts. To determine whether the upregulation of MMP-9 in fibroblasts was associated with the expression of CD14, we incubated the fibroblasts with or without rCD14 (endotoxin level, Ͻ0.1 ng per 1 g of the cytokines, determined by the LAL method). Indeed, the activity of MMP-9 was significantly elevated when fibroblasts were preincubated with rCD14 itself, and the activity of MMP-9 was much increased, especially in the presence of rCD14 and with B. burgdorferi, as Fig. 6A and B) . Expression of MMP-9 was also significantly upregulated by rCD14 as determined using real-time RT-PCR (Fig. 6C) . The effect was completely abolished by anti-CD14 antibody (Fig. 6A, B , and C). MMP-9 production by rCD14 with or without B. burgdorferi in fibroblasts was not affected by 50-g/ml polymyxin B, an inhibitor of LPS activation.
DISCUSSION
We have demonstrated that the expression of MMP-9 was selectively upregulated in human EM skin lesions with acute Lyme disease. The activated fibroblasts and infiltrating mononuclear cells were the major sources of local MMP-9 production (43). Infiltration of skin with mononuclear cells is frequently observed in EM lesions with acute Lyme disease (3). Monocyte/ macrophage infiltration is prominently observed in tissue specimens infected with B. burgdorferi for both humans and experimentally infected animals (29, 31) . In this study, we demonstrate (i) that concentrations of MMP-9 and sCD14 are significantly elevated in serum of the patients with acute Lyme disease and (ii) that upregulation of MMP-9 involves a CD14 signaling pathway in cultured U937 cells and fibroblasts.
The expression of MMP-9 in primary neural cultures was induced in a dose-and time-dependent manner by B. burgdorferi. Human and rat type I astrocytes expressed MMP-9 when incubated with B. burgdorferi in the same manner as primary neural cultures (30) . B. burgdorferi has been demonstrated to induce the secretion and activation of MMP-9 from primary human cells, including monocytes, neutrophils, keratinocytes, and astrocytes (11) . But what mechanism of upregulation of MMP-9 by B. burgdorferi will be involved? B. burgdorferi possesses inherent stimulatory properties, believed to be mediated by spirochetal lipoproteins, which may be responsible for eliciting much of the pathology of Lyme disease (34) . CD14 is a 55-kDa glycoprotein expressed on the surfaces of various cells, including monocytes, macrophages, neutrophils, and chondrocytes. CD14 can be found in a membrane-bound state and a circulating soluble state. Both human endothelial cells (sCD14) and neutrophils (mCD14) appear to attain a greater sensitivity to B. burgdorferi lipoproteins by utilizing CD14 for signaling. Enhanced expression of CD14 and HLA-DR by EM lesional neutrophils and macrophages indicated that these innate effector cells were highly activated (32) . The pathway for B. burgdorferi to activate or elicit an increase in the release of MMP-9 by host cells could be either direct or indirect (i.e., either by acting on cells via receptors to increase their production of MMPs or by increasing the release of other mediators, such as cytokines, which could stimulate the release of MMPs). Our study indicated that the expression of both mCD14 and sCD14 was significantly increased from U937 cells in the presence of B. burgdorferi, which was associated with the upregulation of MMP-9 by B. burgdorferi. Indeed, the anti-CD14 antibody could partially block the expression of MMP-9 from U937 cells with B. burgdorferi. This suggested that the upregulation of MMP-9 by B. burgdorferi in U937 cells could involve a CD14 signaling pathway. MMP-9 but not MMP-1 was specifically induced in monocytic cells through TLR2 by B. burgdorferi (12) . Due to the partially blocked expression of MMP-9 by anti-CD14 antibody, other pathways may also be involved, such as TLR2, TLR4, or other TLRs (4, 20) .
In this study, functional activity of MMP-9 was not detected in human fibroblasts using zymography and a targeted gene array. But MMP-9 mRNA was expressed in fibroblasts at baseline when the more-sensitive technique, real-time RT-PCR, was used. However, the expression of MMP-9 was not impacted in the presence of B. burgdorferi because CD14 (mCD14 or sCD14) was not expressed in fibroblasts.
One of the most interesting findings in this study was that the expression of MMP-9 was significantly increased when fibroblasts were incubated with the conditional medium that contained sCD14 receptor. This finding indicated that upregulation of MMP-9 was associated with increased sCD14 production. Upregulation of MMP-9 could be completely abolished by an anti-CD14 antibody. Although the origin of sCD14 is unclear, sCD14 is shed from the surfaces of monocytes upon activation by gamma interferon, LPS, and other stimuli, suggesting that sCD14 is derived from GPI-anchored mCD14 (6, 17, 27, 28, 39) .
Our results also indicated that recombinant CD14 itself could induce the expression of MMP-9 in fibroblasts. Likewise, the concentration of sCD14 was elevated in the serum of patients with bacterial infections (14, 26, 27) as well as in that from those with autoimmune disorders and rheumatic diseases (1, 5, 8, 33) . sCD14 is a proinflammatory molecule which is increased in inflammation (24) . Nevertheless, the function of sCD14 in vivo is not yet known, and functional studies should complement the quantitative analyses. Moreover, the expression level of MMP-9 was much higher when fibroblasts were cultured in the presence of both recombinant sCD14 and B. burgdorferi. This effect was completely blocked by anti-CD14 antibody. The mechanism of the upregulation of MMP-9 by B. burgdorferi via a CD14 signaling pathway remained to be determined. It is possible that there is no direct binding of the bacterial cell wall to monocytes but that it occurs via the intermediate of CD14, which binds spirochetal lipoproteins and transfers these molecules to the cell membranes of sensitive cells, where they are recognized by specific receptors capable of directly mediating lipoprotein signaling (24) . sCD14 can bind to whole bacteria and bacterial cell wall components and mediates bacterium-induced activation of cells that do not express membrane-bound CD14 as well as CD14-bearing cells (19, 23) . Some studies demonstrated that OspA directly interacted with CD14 in vitro, forming a unique complex that migrated independently of free OspA and CD14 on native gels. Complex formation with CD14 exhibited some degree of specificity and appeared to be lipid mediated (41) . B. burgdorferi lipoproteins induced cellular activation by a mechanism that did not involve the LPS receptor, and CD14 was involved in cellular activation by spirochetal lipoproteins, although likely by using a set of transmembrane proteins different from the one utilized by LPS to transduce the signals (13) . B. burgdorferi lipoproteins also stimulated cytokine production via a CD14-mediated mechanism, thus supporting the contention that CD14 was a pattern recognition receptor as shown by its unique ability to recognize several structurally related microbial antigens (40) . But contrary to an anticipated diminution in pathology, CD14 Ϫ/Ϫ mice exhibited more severe and persistent inflammation than did CD14 ϩ/ϩ mice (2). Our findings demonstrated that B. burgdorferi could induce the expression of MMP-9 via a CD14 signaling pathway. We also proved that sCD14 may play a role in the expression of MMP-9 from fibroblasts which showed a lack of CD14 (16) . We postulated the possibility that the U937 cells stimulated by B. burgdorferi produced the proinflammatory cytokines and MMP-9 via an increased CD14 signaling pathway, and then the released sCD14 may in turn function as receptors for fibroblasts to produce MMP-9 and/or proinflammatory cytokines. The upregulation of MMP-9 by B. burgdorferi involved a CD14 pathway in infiltrating mononuclear cells in acute Lyme disease. The activated fibroblasts can be recruited to amplify local production of MMP-9 by acquiring sCD14 from infiltrating mononuclear cells. This cascade may play an important role in the pathogenesis of acute Lyme disease.
